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Stellate Cells as Agents of Pancreatic Fibrosis
Liver stellate cells, formerly known as Ito or fat-storage cells, are the major agents of liver fibrosis leading to cirrhosis.
Similar cells have been described in the pancreas and the kidney (glomerular mesangial cells). Pancreatic stellate cells
(PSC) can be activated to express -smooth muscle actin and replicate. Both in liver and pancreas, stellate cells appear
to function as wound healing myofibroblasts after injury, secreting various cytokines and growth factors as well as
collagens. Fibrosis is controlled by both collagen deposition and matrix degradation involving metalloproteinases
(MMPs) and tissue inhibitors of metalloproteinases (TIMPs), both of which are regulated in part by TGF. Shek et al (Am J
Pathol 2002, 160:1787–1798) show that PSC express mRNAs for pro-collagen 1, MMPs, and TIMPs. The cells contain
TGF receptors types I and II and secrete active TGF1 into the medium. The data demonstrate that PSC express
collagens and mediators of matrix remodeling which are under TG1 autocrine control, suggesting that PSC are key
mediators of fibrogenic responses in the pancreas.
Angiopoietin-1 Protects against Diabetic Retinopathy
Angiopoietin-1 enhances endothelial cell survival without inducing cell proliferation. It stabilizes endothelial cell interac-
tions with surrounding cells and antagonizes vascular endothelial growth factor (VEGF) effects on vessel permeability.
In diabetic retinopathy in human and rodents there is increased expression of the adhesion molecule 1CAM-1 and
leukocyte adherence, leading to endothelial cell injury and capillary occlusion. Joussen et al (Am J Pathol 2002,
160:1683–1693) show that intravitreal administration of angiopoietin-1 to diabetic rats decreases retinal VEGF and
1CAM-1 (both mRNA and protein) and reduces endothelial cell injury. The authors obtained similar results by systemic
administration of an adenovirus that expressed angiopoietin-1. Inhibition of retinopathy was associated with reduction in
eNOS, nitric oxide, and other mediators of VEGF activity and leukocyte adhesion. The work shows that angiopoietin-1,
a naturally occurring protein, is highly protective against diabetic retinopathy.
TSG-14, a TNF Target Gene that Regulates TNF Biological Effects
Inflammatory responses, depending on their intensity and causes, can be beneficial or harmful to the host. Tumor
necrosis factor (TNF), a key regulatory cytokine in inflammation, has been extensively studied as to its mechanisms of
action and target genes. Among these genes is TSG-14, which is induced by TNF, 1L-1, and LPS, and belongs to the
long pentraxin family of proteins. In contrast to other acute phase proteins, TSG-14 is not expressed in the liver but is
detected mostly in skeletal and myocardial muscle endothelial cells and stimulated macrophages. Previous studies
showed that mice overexpressing TSG-14 have increased resistance to LPS and higher survival rate in experimental
peritonitis. These animals produce high levels of TNF after LPS injection. Souza et al (Am J Pathol 2002, 160:1755–1765)
show that TSG-14 transgenic mice have reduced survival after ischemia/reperfusion injury created by temporary
occlusion of the superior mesenteric artery. TNF is an important mediator of the response since injection of soluble TNF
receptor prevented lethality after ischemia/reperfusion. The data indicate that TSG-14 can regulate TNF biological
activities, both to prevent or promote injury.
Parkin Is a Component of Lewy Bodies in Parkinson’s Disease
Lewy body formation is a characteristic feature of Parkinson’s disease (PD). Parkin mutations are present in autosomal
recessive early-onset parkinsonism which is similar to sporadic PD. Lewy bodies are detected in sporadic and
-synuclein mutated PD but generally not in parkin-associated PD. Parkin is a member of a family of zinc-binding proteins
which have ubiquitin ligase activity that promotes proteasome 1 degradation of proteins. Schlossmacher et al (Am J
Pathol 2002, 160:1655–1667) report that anti-parkin antibodies labeled Lewy bodies in sporadic, parkin-linked, and
inherited -synuclein PD, as well as in dementia with Lewy bodies. -synuclein and parkin co-localized in brain stem and
cortical Lewy bodies. Presynaptic fractions rich in -synuclein also contained parkin and its binding partner, Ubc H7. The
work shows that parkin is present in subcellular compartments of normal brain and co-localizes with -synuclein in PD’s
Lewy bodies, suggesting that parkin may be required for Lewy body formation.
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Targeting Epstein-Barr Virus Sequences in Post-Transplant Lymphomas
One of the complications of organ and bone marrow transplantation is the development of B cell lymphomas associated
with Epstein-Barr virus (EBV). High doses of immunosuppressants such as cyclosporine increase the risk of post-
transplant lymphoproliferative disorders (PTLD) while reduction in dose or withdrawal of immunosuppressive agents
generally leads to tumor regression. Cytotoxic lymphocytes (CTL) responding to irradiated EBV-transformed B lympho-
cytes have also been used to induce regression or prevent PTLD in bone marrow transplant recipients, without
development of graft versus host disease. In these studies a single EBV laboratory strain (B95–8) was used to transform
CTLs. Tao et al (Am J Pathol 2002, 160:1839–1845) asked whether this viral strain shares epitopes with EBV genomes
present in PTLD that can be recognized by EBV-specific CTLs. They characterized the viral strain and the sequence of
commonly recognized CTL epitopes in 25 PTLD specimens and reported that 24 of 25 specimens contained EBV
subtype A. However, CTLs to B95–8 peptides targeted the sequences of the EBV strain present in PTLD tumors. Thus,
these cells may be effective agents for immune therapy of post-transplant lymphomas.
FISHing for GOLDFISH: A New Technique to Detect HER-2/neu Amplification
Detection of HER-2/neu overexpression and amplification is widely used for the management of patients with breast
tumors and to evaluate the response to therapy. Gene amplification can be detected by a variety of methods including
fluorescence in situ hybridization (FISH). A limitation of FISH methodology is that tissue and cell morphology is not
visualized. Moreover, fading and bleaching of the fluorescence signal present difficulties for archiving and documen-
tation. Tubbs et al (Am J Pathol 2002, 160:1589–1595) developed a method for detection of Her-2/neu amplification
using bright-field microscopy without oil immersion. The technique, which they named as GOLDFISH (for gold-facilitated
in situ hybridization), was validated by analyzing 100 invasive breast carcinomas for which Her-2/neu gene copy number
and RNA and protein expression assays were available. Autometallographic gold-based in situ hybridization correlated
well with FISH analysis and offered the additional advantage of morphological visualization on the same slide.
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